+1 201 314 5432

Investor

 

We have completed a US $3.5 million Seed financing round. A Series A financing round of US $25 million is planned for the first half of 2017.

For further information, please contact CEO George Elston or Amy Raskopf.

2X Oncology Overview 6-20-17

2X Oncology Presentation: June 2017 (PDF)